Oncology Market In India 2026-2030

Description

The oncology market in india is forecasted to grow by USD 2359.5 mn during 2025-2030, accelerating at a CAGR of 20.0% during the forecast period. The report on the oncology market in india provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising cancer incidence and growing disease awareness, expansion of oncology healthcare infrastructure and specialized treatment centers, increasing adoption of advanced therapies and pharmaceutical innovation.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Market Scope
Base Year	2026
End Year	2030
Series Year	2026-2030
Growth Momentum	Accelerate
YOY 2026	16.4%
CAGR	20%
Incremental Value	$2359.5 mn

Technavio's oncology market in india is segmented as below:

By Type

Cancer treatment
Cancer diagnostics

By End-User

Hospitals
Diagnostic laboratories
Diagnostic imaging centers
Others

By Disease Type

Breast cancer
Lung cancer
Blood cancer
Colorectal cancer
Others

Geography

Asia

This study identifies the gradual shift toward precision and personalized oncology care as one of the prime reasons driving the oncology market in india growth during the next few years. Also, increasing role of biosimilars in expanding treatment options and expansion of integrated cancer care and multidisciplinary treatment models will lead to sizable demand in the market.

The report on the oncology market in india covers the following areas:

Oncology market in india sizing
Oncology market in india forecast
Oncology market in india industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading oncology market in india vendors that include Abbott Laboratories, Alkem Laboratories Ltd., AstraZeneca Plc, Baxter International Inc., Biocon Ltd., Bristol Myers Squibb Co., Cipla Inc., Dr. Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., GE Healthcare Technologies, Glenmark Pharmaceuticals Ltd., Lupin Ltd., Medtronic Plc, Merck and Co. Inc., Natco Pharma Ltd., Novartis AG, Poly Medicure Ltd., Siemens Healthineers AG, Sun Pharmaceutical Industries Ltd., Zydus Lifesciences Ltd.. Also, the oncology market in india analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR71137

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Country Market Characteristics
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Disease Type
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030

3 Market Landscape

3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Chart on Market characteristics analysis
3.3 Value chain analysis
- Chart on Value chain analysis

4 Market Sizing

4.1 Market definition
- Data Table on Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2025
4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

5.1 Oncology Market in India 2020 - 2024
- Historic Market Size - Data Table on Oncology Market in India 2020 - 2024 ($ million)
5.2 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
5.3 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
5.4 Disease Type segment analysis 2020 - 2024
- Historic Market Size - Disease Type Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

6.1 Impact of AI in oncology market in India

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
7.7 Market condition
- Chart on Market condition - Five forces 2025 and 2030

8 Market Segmentation by Type

8.1 Market segments
- Chart on Type - Market share 2025-2030 (%)
- Data Table on Type - Market share 2025-2030 (%)
8.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
8.3 Cancer treatment - Market size and forecast 2025-2030
- Chart on Cancer treatment - Market size and forecast 2025-2030 ($ million)
- Data Table on Cancer treatment - Market size and forecast 2025-2030 ($ million)
- Chart on Cancer treatment - Year-over-year growth 2025-2030 (%)
- Data Table on Cancer treatment - Year-over-year growth 2025-2030 (%)
8.4 Cancer diagnostics - Market size and forecast 2025-2030
- Chart on Cancer diagnostics - Market size and forecast 2025-2030 ($ million)
- Data Table on Cancer diagnostics - Market size and forecast 2025-2030 ($ million)
- Chart on Cancer diagnostics - Year-over-year growth 2025-2030 (%)
- Data Table on Cancer diagnostics - Year-over-year growth 2025-2030 (%)
8.5 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)

9 Market Segmentation by End-user

9.1 Market segments
- Chart on End-user - Market share 2025-2030 (%)
- Data Table on End-user - Market share 2025-2030 (%)
9.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
9.3 Hospitals - Market size and forecast 2025-2030
- Chart on Hospitals - Market size and forecast 2025-2030 ($ million)
- Data Table on Hospitals - Market size and forecast 2025-2030 ($ million)
- Chart on Hospitals - Year-over-year growth 2025-2030 (%)
- Data Table on Hospitals - Year-over-year growth 2025-2030 (%)
9.4 Diagnostic laboratories - Market size and forecast 2025-2030
- Chart on Diagnostic laboratories - Market size and forecast 2025-2030 ($ million)
- Data Table on Diagnostic laboratories - Market size and forecast 2025-2030 ($ million)
- Chart on Diagnostic laboratories - Year-over-year growth 2025-2030 (%)
- Data Table on Diagnostic laboratories - Year-over-year growth 2025-2030 (%)
9.5 Diagnostic imaging centers - Market size and forecast 2025-2030
- Chart on Diagnostic imaging centers - Market size and forecast 2025-2030 ($ million)
- Data Table on Diagnostic imaging centers - Market size and forecast 2025-2030 ($ million)
- Chart on Diagnostic imaging centers - Year-over-year growth 2025-2030 (%)
- Data Table on Diagnostic imaging centers - Year-over-year growth 2025-2030 (%)
9.6 Others - Market size and forecast 2025-2030
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
9.7 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)

10 Market Segmentation by Disease Type

10.1 Market segments
- Chart on Disease Type - Market share 2025-2030 (%)
- Data Table on Disease Type - Market share 2025-2030 (%)
10.2 Comparison by Disease Type
- Chart on Comparison by Disease Type
- Data Table on Comparison by Disease Type
10.3 Breast cancer - Market size and forecast 2025-2030
- Chart on Breast cancer - Market size and forecast 2025-2030 ($ million)
- Data Table on Breast cancer - Market size and forecast 2025-2030 ($ million)
- Chart on Breast cancer - Year-over-year growth 2025-2030 (%)
- Data Table on Breast cancer - Year-over-year growth 2025-2030 (%)
10.4 Lung cancer - Market size and forecast 2025-2030
- Chart on Lung cancer - Market size and forecast 2025-2030 ($ million)
- Data Table on Lung cancer - Market size and forecast 2025-2030 ($ million)
- Chart on Lung cancer - Year-over-year growth 2025-2030 (%)
- Data Table on Lung cancer - Year-over-year growth 2025-2030 (%)
10.5 Blood cancer - Market size and forecast 2025-2030
- Chart on Blood cancer - Market size and forecast 2025-2030 ($ million)
- Data Table on Blood cancer - Market size and forecast 2025-2030 ($ million)
- Chart on Blood cancer - Year-over-year growth 2025-2030 (%)
- Data Table on Blood cancer - Year-over-year growth 2025-2030 (%)
10.6 Colorectal cancer - Market size and forecast 2025-2030
- Chart on Colorectal cancer - Market size and forecast 2025-2030 ($ million)
- Data Table on Colorectal cancer - Market size and forecast 2025-2030 ($ million)
- Chart on Colorectal cancer - Year-over-year growth 2025-2030 (%)
- Data Table on Colorectal cancer - Year-over-year growth 2025-2030 (%)
10.7 Others - Market size and forecast 2025-2030
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
10.8 Market opportunity by Disease Type
- Market opportunity by Disease Type ($ million)
- Data Table on Market opportunity by Disease Type ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Drivers, Challenges, and Opportunity

12.1 Market drivers
- Rising cancer incidence and growing disease awareness
- Expansion of oncology healthcare infrastructure and specialized treatment centers
- Increasing adoption of advanced therapies and pharmaceutical innovation
12.2 Market challenges
- High cost of cancer treatment and limited affordability
- Uneven access to oncology services
- Late diagnosis and limited screening coverage
12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
12.4 Market opportunities
- Gradual shift toward precision and personalized oncology care
- Increasing role of biosimilars in expanding treatment options
- Expansion of integrated cancer care and multidisciplinary treatment models

13 Competitive Landscape

13.1 Overview
13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
13.3 Landscape disruption
- Overview on factors of disruption
13.4 Industry risks
- Impact of key risks on business

14 Competitive Analysis

14.1 Companies profiled
- Companies covered
14.2 Company ranking index
- Company ranking index
14.3 Market positioning of companies
- Matrix on companies position and classification
14.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
14.5 Alkem Laboratories Ltd.
- Alkem Laboratories Ltd. - Overview
- Alkem Laboratories Ltd. - Business segments
- Alkem Laboratories Ltd. - Key offerings
- Alkem Laboratories Ltd. - Segment focus
- SWOT
14.6 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- SWOT
14.7 Bristol Myers Squibb Co.
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
- SWOT
14.8 Cipla Inc.
- Cipla Inc. - Overview
- Cipla Inc. - Business segments
- Cipla Inc. - Key news
- Cipla Inc. - Key offerings
- Cipla Inc. - Segment focus
- SWOT
14.9 Dr. Reddys Laboratories Ltd.
- Dr. Reddys Laboratories Ltd. - Overview
- Dr. Reddys Laboratories Ltd. - Business segments
- Dr. Reddys Laboratories Ltd. - Key news
- Dr. Reddys Laboratories Ltd. - Key offerings
- Dr. Reddys Laboratories Ltd. - Segment focus
- SWOT
14.10 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
14.11 GE Healthcare Technologies
- GE Healthcare Technologies - Overview
- GE Healthcare Technologies - Business segments
- GE Healthcare Technologies - Key news
- GE Healthcare Technologies - Key offerings
- GE Healthcare Technologies - Segment focus
- SWOT
14.12 Glenmark Pharmaceuticals Ltd.
- Glenmark Pharmaceuticals Ltd. - Overview
- Glenmark Pharmaceuticals Ltd. - Product / Service
- Glenmark Pharmaceuticals Ltd. - Key offerings
- SWOT
14.13 Lupin Ltd.
- Lupin Ltd. - Overview
- Lupin Ltd. - Business segments
- Lupin Ltd. - Key news
- Lupin Ltd. - Key offerings
- Lupin Ltd. - Segment focus
- SWOT
14.14 Merck and Co. Inc.
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- SWOT
14.15 Natco Pharma Ltd.
- Natco Pharma Ltd. - Overview
- Natco Pharma Ltd. - Product / Service
- Natco Pharma Ltd. - Key offerings
- SWOT
14.16 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
14.17 Sun Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd. - Overview
- Sun Pharmaceutical Industries Ltd. - Product / Service
- Sun Pharmaceutical Industries Ltd. - Key news
- Sun Pharmaceutical Industries Ltd. - Key offerings
- SWOT
14.18 Zydus Lifesciences Ltd.
- Zydus Lifesciences Ltd. - Overview
- Zydus Lifesciences Ltd. - Business segments
- Zydus Lifesciences Ltd. - Key news
- Zydus Lifesciences Ltd. - Key offerings
- Zydus Lifesciences Ltd. - Segment focus
- SWOT

15 Appendix

15.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
15.3 Currency conversion rates for US$
- Currency conversion rates for US$
15.4 Research methodology
- Research methodology
15.5 Data procurement
- Information sources
15.6 Data validation
- Data validation
15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
15.8 Data synthesis
- Data synthesis
15.9 360 degree market analysis
- 360 degree market analysis
15.10 List of abbreviations
- List of abbreviations